Vaccines

Evonik Boosts Supply of Plant-Derived Cholesterol for mRNA Vaccines and Gene Therapies

Strategic Insights

Mar 4, 2022 — 1 min read

Evonik Industries AG, a leading specialty chemicals company, has announced a significant expansion of its plant-derived cholesterol production in Hanau, Germany. This move aims to meet the growing demand for PhytoChol(r), a critical component used in lipid nanoparticles (LNPs) for COVID-19 vaccines and other mRNA-based therapeutics. The increased supply of PhytoChol(r) will support the growth of Evonik's Health Care business, which is part of the Nutrition & Care division. As part of its strategy to strengthen its portfolio of system solutions, Nutrition & Care aims to increase its share of such solutions from 20% today to over 50% by 2030.

Key Takeaways:

Evonik has boosted its supply of plant-derived cholesterol, PhytoChol(r), to meet the growing demand for mRNA-based therapeutics and vaccines.
PhytoChol(r) is a critical component used in lipid nanoparticles (LNPs) for COVID-19 vaccines and other mRNA-based treatments.
The increased supply of PhytoChol(r) will support the growth trajectory of Evonik's Health Care business, which is a part of the Nutrition & Care division.
Evonik's Health Care business aims to increase the share of system solutions from 20% today to over 50% by 2030.
PhytoChol(r) is non-animal derived and minimizes risks associated with cholesterol from animal origin, such as undesired immunological responses and inconsistent quality.
Evonik Health Care has been a leader in advanced drug delivery for many decades, supporting pharmaceutical companies worldwide with end-to-end CDMO services.

Statistics:

PhytoChol(r) is a critical excipient for mRNA and gene therapies as well as biopharmaceutical cell culture applications.
Evonik's Nutrition & Care division has a target to increase the share of system solutions from 20% to over 50% by 2030.
Evonik has a long history of supporting pharmaceutical companies worldwide with end-to-end CDMO services for the development and production of complex parenteral drug products.

Sources:

Evonik Industries AG. Press release: Evonik Boosts Supply of Plant-Derived Cholesterol.

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients